11611 N. MERIDIAN ST, CARMEL, IN
Market cap: $51.7M (2/11/2026)
Price: $4.85
FDA 510(k) Clearance for NeurAxis' PENFS Technology for FAP Treatment
Neuraxis, Inc. Reports Q3 2025 Financial Results and Cash Position
News, Underwriting Agreement, Legal Opinion
News, Material Contracts
Shareholder votes
Investor Presentation
Announces $5.0 Million Registered Direct Offering
Material Contracts, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Events
Q3
Q2
Q1
FY 2024
Notice of Late Filing for Quarterly Report
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload
Free Writing Prospectus